Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Neil Osterweil

News

Low-dose aspirin reduces liver fat, inflammation markers

Author:
Neil Osterweil
Publish date: November 17, 2023

“I’m encouraged by the results with low-dose aspirin, and I think that, given the risk profile, using a lower dose is preferable.”

  • Read More

News

Weight-loss drugs improve liver measures, too

Author:
Neil Osterweil
Publish date: November 15, 2023

Body weight reduction of at least 3% within 8 weeks of beginning treatment with either an SLT-2 or GLP-1 agent was associated independently with...

  • Read More

News

MASLD, MASH projected to grow by 23% in the U.S. through 2050

Author:
Neil Osterweil
Publish date: November 9, 2023

“In the absence of effective treatments, health systems should plan for large increases in the number of liver cancer cases and the need for liver...

  • Read More

News

ACORN: No excess AKI with pip-tazo vs. cefepime

Author:
Neil Osterweil
Publish date: November 6, 2023

Results of the randomized trial suggest that clinicians can safely prescribe empiric piperacillin-tazobactam for serious acute infections.

  • Read More

News

Race-specific lung-function values may skew IPF testing

Author:
Neil Osterweil
Publish date: November 1, 2023

Race-specific equations may falsely inflate percent-predicted pulmonary function values in non-White patients, investigators caution.

  • Read More

News

Dato-DXd trumps chemo in advanced HR+/HER2– breast cancer

Author:
Neil Osterweil
Publish date: October 25, 2023

The antibody-drug conjugate datopotamab deruxtecan had better efficacy and safety than chemotherapy for patients with endocrine-resistant...

  • Read More

News

Sputum microbiome may augur treatment success in NTM-PD

Author:
Neil Osterweil
Publish date: October 23, 2023

Patients cured of nontuberculosis mycobacterial infections with antibiotics had greater species diversity in sputum than those with refractory...

  • Read More

News

ICIs improve pCR rates in early ER+/HER2– breast cancer

Author:
Neil Osterweil
Publish date: October 22, 2023

Nivolumab and pembrolizumab boosted pathologic complete response rates when added to neoadjuvant and adjuvant therapy in patients with high-risk...

  • Read More

News

No benefit to adding ICI to chemo in triple-negative breast cancer: study

Author:
Neil Osterweil
Publish date: October 22, 2023

There were no differences in 5-year event-free survival among patients with TNBC who received neoadjuvant chemotherapy with or without...

  • Read More

News

Adjuvant abemaciclib-ET combo shows long-term benefit in high-risk early breast cancer

Author:
Neil Osterweil
Publish date: October 20, 2023

Invasive disease–free and distant recurrence–free survival were better with the CDK4/6 inhibitor plus endocrine therapy than endocrine therapy...

  • Read More

News

Asthma severity higher among LGBTQ+ population

Author:
Neil Osterweil
Publish date: October 18, 2023

SGM respondents were significantly more likely to have had asthma attacks requiring steroid use in the past years.

  • Read More

News

Pulmonary hypertension increases ARDS mortality risk

Author:
Neil Osterweil
Publish date: October 18, 2023

The presence of PH was associated with about a 50% higher risk for in-hospital mortality.

  • Read More

News

The dawning age of therapy for Friedreich ataxia

Author:
Neil Osterweil
Publish date: October 13, 2023

The first therapy to target the underlying pathology of Friedreich ataxia was approved in 2023. Other drug and genetic therapies are in the...

  • Read More

News

Nintedanib dose reductions in IPF may do no harm

Author:
Neil Osterweil
Publish date: October 11, 2023

Patients with idiopathic pulmonary fibrosis who required dose reductions had similar all-cause mortality and death rates vs. patients on the full...

  • Read More

News

Dietary changes to microbiome may improve lung function

Author:
Neil Osterweil
Publish date: October 10, 2023

What we eat and what’s in the gut may influence lung health for better or worse.

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close